MARATTO

review

Impact of Sodium-glucose co-transporter 2 inhibitors on Atrial Fibrillation Recurrence Post- catheter ablation among patients with type 2 diabetes mellitus: A systematic review and meta-analysis

20242 citationsOpen accessMinia University

Abstract

Background Atrial fibrillation (AF) is the most common cause of arrhythmia-induced cardiomyopathy. Effective management strategies include medical therapy for rate and rhythm control, catheter ablation (CA), and goal directed medical therapy. Sodium-g

Research topics

  • Atrial Fibrillation Management and Outcomes
  • Diabetes Treatment and Management
  • Cardiac Arrhythmias and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.22541/au.172488359.94003509/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.